Treatment for novel coronavirus shows promise in early lab tests

April 18, 2013, NIH/National Institute of Allergy and Infectious Diseases
This is a transmission electron micrograph of the novel coronavirus. Credit: NIAID/RML

National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells. These results suggest that the drug combination could be used to treat patients infected with the new coronavirus, but more research is needed to confirm this preliminary finding. The study appears in the April 18, 2013, issue of Scientific Reports.

The new coronavirus, called nCoV, was first identified in Saudi Arabia in September 2012. As of April 16, 2013, the has reported 17 cases with 11 deaths, primarily in the Middle East. Although the case count is small, the new coronavirus has transmitted from human-to-human in situations where people—mainly family members—have had close contact with those infected.

Because of the high , scientists at NIH's National Institute of Allergy and Infectious Diseases (NIAID) saw an urgent need to identify therapeutic options. In laboratory tests using cells from two species of monkey, the researchers found that either ribavirin or interferon-alpha 2b, drugs currently approved for therapy, inhibited nCoV from replicating when used individually. However, the required drug concentrations exceeded what is recommended for people. By combining the two antivirals, the scientists established an effective treatment dose at a drug level that is achievable in people. The NIAID researchers plan to confirm these results in a recently developed monkey model of nCoV infection.

Explore further: Emirati man dies of SARS-linked virus in Germany (Update)

More information: Falzarano et al. Inhibition of novel human coronavirus-EMC replication by a combination of interferon-alpha2b and ribavirin. Scientific Reports DOI: 10.1038/srep01686 (2013).

Munster et al. Novel Human Coronavirus Causes Pneumonia in a Macaque Model Resembling Human Disease. New England Journal of Medicine DOI: 10.1056/NEJMc1215691 (2013).

Related Stories

Emirati man dies of SARS-linked virus in Germany (Update)

March 26, 2013
A man from the United Arab Emirates who was infected with a new SARS-related virus has died in Munich, German authorities said Tuesday.

WHO: Two more cases of new virus in Jordan (Update)

November 30, 2012
International health officials have confirmed two more fatal cases of a mysterious respiratory virus in the Middle East.

UK patient dies from SARS-like coronavirus

February 19, 2013
(AP)—A patient being treated for a mysterious SARS-like virus has died, a British hospital said Tuesday.

SARS-linked virus may have spread between people

February 13, 2013
(AP)—British officials say a mysterious virus related to SARS may have spread between humans, as they confirmed the 11th case worldwide of the new coronavirus in a patient who they say probably caught it from a family member.

New death from SARS-like virus in Saudi, WHO reports

February 21, 2013
Another person suffering from a SARS-like virus has died in Saudi Arabia, the World Health Organization said Thursday, bringing the worldwide number of fatalities from the mystery illness to seven.

Saudi death from SARS-like virus, WHO reports

March 12, 2013
A SARS-like virus that has struck in Britain and the Middle East has claimed a new victim in Saudi Arabia, bringing the global toll from the mystery illness to nine, the World Health Organisation said Tuesday.

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

Don't hold your nose and close your mouth when you sneeze, doctors warn

January 15, 2018
Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors in the journal BMJ Case Reports.

New antifungal provides hope in fight against superbugs

January 12, 2018
Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.